Cinctive Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,479
| Closed | -$352K | – | 449 |
|
|
2024
Q4 | $352K | Sell |
24,479
-138,106
| -85% | -$1.98M | 0.02% | 312 |
|
|
2024
Q3 | $3.67M | Buy |
+162,585
| New | +$3.67M | 0.2% | 159 |
|
|
2024
Q2 | – | Sell |
-13,234
| Closed | -$497K | – | 503 |
|
|
2024
Q1 | $497K | Sell |
13,234
-77,286
| -85% | -$2.9M | 0.02% | 327 |
|
|
2023
Q4 | $5.07M | Buy |
+90,520
| New | +$5.07M | 0.34% | 98 |
|
|
2023
Q3 | – | Sell |
-71,948
| Closed | -$4.02M | – | 481 |
|
|
2023
Q2 | $4.02M | Sell |
71,948
-81,778
| -53% | -$4.57M | 0.13% | 200 |
|
|
2023
Q1 | $8.58M | Buy |
+153,726
| New | +$8.58M | 0.29% | 107 |
|
|
2022
Q4 | – | Sell |
-18,788
| Closed | -$535K | – | 524 |
|
|
2022
Q3 | $535K | Sell |
18,788
-23,267
| -55% | -$663K | 0.02% | 358 |
|
|
2022
Q2 | $1.9M | Buy |
+42,055
| New | +$1.9M | 0.08% | 286 |
|
|
2021
Q2 | – | Sell |
-12,471
| Closed | -$2.26M | – | 600 |
|
|
2021
Q1 | $2.26M | Buy |
+12,471
| New | +$2.26M | 0.14% | 246 |
|